BiotechTube
Home/Sonoma Biotherapeutics/Stephen Dilly, MBBS, PhD
SD

Stephen Dilly, MBBS, PhD

President and Chief Executive Officer

Sonoma Biotherapeutics

Therapeutic Areas

Autoimmune DiseasesInflammatory Diseases

Sonoma Biotherapeutics Pipeline

DrugIndicationPhase
SBT-77-7101Refractory Rheumatoid ArthritisPhase 1

Leadership Team at Sonoma Biotherapeutics

JB
Jeff Bluestone, PhD
Co-founder, Advisor, Board Member
FR
Fred Ramsdell, PhD
Co-founder
View full Sonoma Biotherapeutics profile